Wednesday, 2 October 2013

Yahoo! Finance: Biotechnology Industry News: Oral Apremilast Significantly Improved Nail and Scalp Psoriasis and Health-Related Quality-of-Life Measures in Phase III ESTEEM 1 Study

Yahoo! Finance: Biotechnology Industry News
The latest news on the Biotechnology industry from Yahoo! Finance 
Want new traffic sources?

Download a copy of our complimentary eBook today, and read about sources that most marketers are not aware of.
From our sponsors
Oral Apremilast Significantly Improved Nail and Scalp Psoriasis and Health-Related Quality-of-Life Measures in Phase III ESTEEM 1 Study
Oct 3rd 2013, 06:30

[Business Wire] - Celgene International Sàrl, a wholly-owned subsidiary of Celgene Corporation , today announced results of pre-specified sub-analyses from ESTEEM 1 on nail and scalp ps

You are receiving this email because you subscribed to this feed at blogtrottr.com.

If you no longer wish to receive these emails, you can unsubscribe from this feed, or manage all your subscriptions

No comments:

Post a Comment